MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of Stigma on Patients Diagnosed with Parkinson’s Disease in Buenos Aires (Argentina) : A Descriptive Study of Psychological, Occupational, and Social Dimensions

JS. Bestoso, R. Sanjinez, J. Ayerbe, C. Stefani, L. Ciancaglini, V. Müller, D J. Bauso (Buenos Aires, Argentina)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Parkinsonism

Category: Parkinson's Disease (Other)

Objective: To assess the characteristics and impact of stigma in Parkinson’s disease (PD)patients and explore differences by age, gender, education level, and disease duration.

Background: Stigma can significantly affect patients with PD, influencing self-esteem, quality of life, and leading to potential discrimination.

Method: PD patients under follow-up in our department completed a tailored questionnaire on stigma in occupational, social, and familial contexts. Data on coping strategies, symptom concealment, and quality of life impact were collecte

Results: N=52. Men: 30 (57.7%). Mean age: 69 years (46–86). Time since diagnosis: <3 years: 6 (11.5%); 3–5 years: 10 (19.2%); 5.1–10 years: 24 (45.2%); >10 years: 12 (23.1%). Education: primary: 7 (13.4%); secondary: 18 (34.6%); tertiary/university: 27 (51.9%). Occupational impact: 14 (27%): task reassignment: 4 (28.6%); resignation: 2 (14.3%); absenteeism: 1 (7.1%); dismissal: 1 (7.1%); others: 6 (42.9%). Perceived stigma: 10 (19.2%); doubtful: 11 (21.2%). Diagnosis concealment: 15 (38.5%). Symptom concealment strategies: 25 (62.5%): physical concealment: 15%; avoiding social situations: 12.5%; alternative symptom explanations: 5%. Stigma perceived by others: yes: 24.4%; doubtful: 12.2%; no: 63.4%. Physician discussion on stigma: 12%; more frequent in patients <70 years (21%) vs. older patients (0%), p=0.04. Quality of life impact: negative: 36.5%. Discrimination: 9.4%. Social withdrawal: 17.3%. Greater social withdrawal in those perceiving stigma (60%) vs. those not (3%), OR 45 [4.25, 476], p<0.01.

Conclusion: Stigma perception and impact varied among the studied PD population, affecting occupational, social, and familial contexts, quality of life, and self-esteem. Differences in stigma perception were not significantly associated with age at diagnosis, gender, or education level, except for greater physician discussions on stigma among younger patients and the association of perceived stigma with increased social withdrawal.

References: Ma, H.-I., Saint-Hilaire, M., Thomas, C. A., Tickle-Degnen, L. (2016). “Stigma as a Key Determinant of Health-Related Quality of Life in Parkinson’s Disease.” Quality of Life Research, 25(12), 3037-3045. doi:10.1007/s11136-016-1351-y
Maffoni, M., Giardini, A., Pierobon, A., Ferrazzoli, D., Frazzitta, G. (2017). “Stigma Experienced by Parkinson’s Disease Patients: A Descriptive Review of QualitativeStudies.” Parkinson’s Disease, 2017, 7203259. doi:10.1155/2017/7203259
Moore, S. F., Knowles, S. R., Galea, A. P. (2016). “Perceived Stigma as a Predictor of Disability in Parkinson’s Disease.” Movement Disorders Clinical Practice, 3(4), 431-436. doi:10.1002/mdc3.12317
Ruiz-Peris, M., Lapeña-Moñux, Y. R., Flórez-Grau, M., Pol-Balado, R., Pérez-Campos, E. (2020). “Stigma in Parkinson’s Disease: Correlates and Consequences.” Neurología, 35(9), 608-615. doi:10.1016/j.nrleng.2018.12.009
Van der Eijk, M., Faber, M. J., Al Shamma, S., Munneke, M., Bloem, B. R. (2011). “Moving Towards Patient-Centered Healthcare for Patients with Parkinson’s Disease.” Parkinsonism & Related Disorders, 17(5), 360-364. doi:10.1016/j.parkreldis.2011.02.012
Schrag, A., Jahanshahi, M., Quinn, N. (2000). “What Contributes to Quality of Life in Patients with Parkinson’s Disease?” Journal of Neurology, Neurosurgery & Psychiatry, 69(3), 308-312. doi:10.1136/jnnp.69.3.308
Mak, W. W. S., Cheung, R. Y. M. (2010). “Self-Stigma Among Concealable Minorities in Hong Kong: Conceptualization and Unified Measurement.” American Journal of Orthopsychiatry, 80(2), 267-281. doi:10.1111/j.1939-0025.2010.01030.x
Hecht, H., Ma, H.-I., Tickle-Degnen, L. (2011). “Face Perception and the Challenges of Social Interaction in Parkinson’s Disease.” Movement Disorders, 26(14), 2410-2419. doi:10.1002/mds.23993
Clarke, C. E., Jenner, P. (2004). “Parkinson’s Disease Stigma: An Issue for Patients, Families, and Caregivers.” Parkinsonism & Related Disorders, 10(3), 121-122. doi:10.1016/j.parkreldis.2004.01.003
Tan, S. B., Williams, A. F., Morris, M. E. (2012). “Experiences of Caregivers of People with Parkinson’s Disease in Singapore: A Qualitative Analysis.” Journal of Clinical Nursing, 21(15-16), 2238-2246. doi:10.1111/j.1365-2702.2012.04117.x

To cite this abstract in AMA style:

JS. Bestoso, R. Sanjinez, J. Ayerbe, C. Stefani, L. Ciancaglini, V. Müller, D J. Bauso. Impact of Stigma on Patients Diagnosed with Parkinson’s Disease in Buenos Aires (Argentina) : A Descriptive Study of Psychological, Occupational, and Social Dimensions [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/impact-of-stigma-on-patients-diagnosed-with-parkinsons-disease-in-buenos-aires-argentina-a-descriptive-study-of-psychological-occupational-and-social-dimensions/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-stigma-on-patients-diagnosed-with-parkinsons-disease-in-buenos-aires-argentina-a-descriptive-study-of-psychological-occupational-and-social-dimensions/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley